Primer of Drug Action
Edition after edition, Robert Julien’s A Primer of Drug Action keeps pace with one of the most dynamic fields of scientific inquiry, giving students immediate access to the most current research and promising new directions in psychopharmacology. Rigorously updated throughout, the new edition again takes its place as the definitive guide to the drugs that affect the mind and behavior. As always, it is clear, comprehensive, objective, and authoritative, spanning a wide variety of drug types, including sedatives, depressants, stimulants, analgesics, psychedelic drugs, steroids, and drugs used to treat psychological disorders.
To visit Robert Julien's blog that accompanies A Primer of Drug Action, click here.
What people are saying - Write a review
We haven't found any reviews in the usual places.
abuse action active acute addiction ADHD administration agents agonist alcohol American Journal amphetamine anabolic steroids analgesic antagonist anticonvulsants antidepressant anxiety disorders aripiprazole associated atypical antipsychotic behavioral benzodiazepines bipolar disorder blood brain bupropion caffeine cannabinoid cell Chapter chronic citalopram clozapine cocaine cognitive coworkers 2009 dependence disease dopamine dopaminergic doses Double-Blind drug efficacy enzyme Figure fluoxetine function GABA glutamate half-life impairment increase inhibit inhibitor injection insomnia Journal ofClinical Journal ofPsychiatry lamotrigine levels lithium Major Depressive marijuana medication metabolism metabolite methamphetamine methylphenidate milligrams mood stabilizers morphine naltrexone neurons neurotransmitter nicotine norepinephrine olanzapine omega-3 fatty acids opioid oral pain patients percent pharmacological placebo Placebo-Controlled plasma potential pregnancy presynaptic produce protein psychedelic Psychiatry psychoactive Psychopharmacology psychosis quetiapine receptors reduce relapse reported response result reuptake Review risk risperidone schizophrenia serotonin side effects smoking SSRIs stimulant substance symptoms synaptic syndrome therapeutic therapy tion toxicity transmitter treat treatment Trial varenicline withdrawal